SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-21-000105
Filing Date
2021-06-02
Accepted
2021-06-02 06:08:12
Documents
1
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162262847834335.html 4  
1 FORM 4 wf-form4_162262847834335.xml 4 11043
  Complete submission text file 0001395064-21-000105.txt   12669
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39094 | Film No.: 21987609
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Issuer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations